Starting in mid-January 2021, a mass COVID-19 vaccination campaign among residents, workers, retirees and their families has begun in the Vatican City State. During the month of December, the Directorate of Health and Hygiene decided to adopt the mRNA BNT162b2 vaccine produced by Pfizer and BioNTech, which has been shown to be 95% effective
Mass vaccination campaign for residents and workers and assistance to vulnerable populations during COVID-19 pandemic: the experience of the healthcare services of the Vatican City / Ralli, M.; De-Giorgio, F.; Soave, P. M.; Ercoli, L.; Arcangeli, A.. - In: THE LANCET REGIONAL HEALTH. EUROPE. - ISSN 2666-7762. - 2:(2021). [10.1016/j.lanepe.2021.100053]
Mass vaccination campaign for residents and workers and assistance to vulnerable populations during COVID-19 pandemic: the experience of the healthcare services of the Vatican City
Ralli M.
Primo
;
2021
Abstract
Starting in mid-January 2021, a mass COVID-19 vaccination campaign among residents, workers, retirees and their families has begun in the Vatican City State. During the month of December, the Directorate of Health and Hygiene decided to adopt the mRNA BNT162b2 vaccine produced by Pfizer and BioNTech, which has been shown to be 95% effective| File | Dimensione | Formato | |
|---|---|---|---|
|
Ralli_Mass vaccination campaign_.pdf
accesso aperto
Note: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(21)00030-2/fulltext
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
240.94 kB
Formato
Adobe PDF
|
240.94 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
